Patent Yard Sign in
Canadian application, no grantCanada

Transgenic animal model for neurodegenerative diseases

CA 2383564 A1 · Owner: Lubbert, Hermann · Inventors: Lubbert, Hermann

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present application refers to a mouse parkin2 DNA- and protein sequence containing mutations or deletions causing Parkinson's disease in a human if occurring in the according human sequence the construction of a transgenic , non-human animal containing such a mutated DNA sequence and therefore expressing no or a less active or non-active parkin protein as well as the use of this transgenic animal as a model for neurodegenerative diseases.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 18, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 18, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 18, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 18, 2000
GrantedNo grant recorded
Term endedAugust 18, 2020
Patent numberCA 2383564 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedAug 18, 2000Term endedAug 18, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.